Log on / register
Feedback | Support | My details
Open AccessHighly AccessCase report

Neuroacanthocytosis associated with a defect of the 4.1R membrane protein

Antonio Orlacchio1,2 email, Paolo Calabresi3,4 email, Adriana Rum2 email, Anna Tarzia5 email, Anna Maria Salvati5 email, Toshitaka Kawarai6 email, Alessandro Stefani2 email, Antonio Pisani2,4 email, Giorgio Bernardi1,2,4 email, Paolo Cianciulli7 email and Patrizia Caprari5 email

Laboratorio di Neurogenetica, Centro Europeo di Ricerca sul Cervello (CERC) – Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Santa Lucia, Rome, Italy

Dipartimento di Neuroscienze, Neurologia, Università di Roma "Tor Vergata", Rome, Italy

Dipartimento di Specialità Medico-Chirurgiche e Sanità Pubblica, Neurologia, Università di Perugia, Perugia, Italy

Laboratorio di Neurofisiologia Sperimentale, Centro Europeo di Ricerca sul Cervello (CERC) – Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Santa Lucia, Rome, Italy

Dipartimento di Ematologia, Oncologia e Medicina Molecolare, Istituto Superiore di Sanità, Rome, Italy

Department of Neurology, Hyogo Brain and Heart Center, Himeji city, Hyogo prefecture, Japan

Day Hospital Talassemici, Ospedale S. Eugenio, Rome, Italy

author email corresponding author email

BMC Neurology 2007, 7:4doi:10.1186/1471-2377-7-4

Published: 13 February 2007

Abstract

Background

Neuroacanthocytosis (NA) denotes a heterogeneous group of diseases that are characterized by nervous system abnormalities in association with acanthocytosis in the patients' blood. The 4.1R protein of the erythrocyte membrane is critical for the membrane-associated cytoskeleton structure and in central neurons it regulates the stabilization of AMPA receptors on the neuronal surface at the postsynaptic density. We report clinical, biochemical, and genetic features in four patients from four unrelated families with NA in order to explain the cause of morphological abnormalities and the relationship with neurodegenerative processes.

Case presentation

All patients were characterised by atypical NA with a novel alteration of the erythrocyte membrane: a 4.1R protein deficiency. The 4.1R protein content was significantly lower in patients (3.40 ± 0.42) than in controls (4.41 ± 0.40, P < 0.0001), reflecting weakened interactions of the cytoskeleton with the membrane. In patients IV:1 (RM23), IV:3 (RM15), and IV:6 (RM16) the 4.1 deficiency seemed to affect the horizontal interactions of spectrin and an impairment of the dimer self-association into tetramers was detected. In patient IV:1 (RM16) the 4.1 deficiency seemed to affect the skeletal attachment to membrane and the protein band 3 was partially reduced.

Conclusion

A decreased expression pattern of the 4.1R protein was observed in the erythrocytes from patients with atypical NA, which might reflect the expression pattern in the central nervous system, especially basal ganglia, and might lead to dysfunction of AMPA-mediated glutamate transmission.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.